Latest Updates

Revenue up four per cent to Rs 441 crores, Profit After Tax increases nine per cent to Rs 72 crores. Further, Dr Mahesh Bhalgat…

Plazomicin is a IV aminoglycoside with once-daily dosing for cUTI in adults, with proven activity against certain drug-resistant…

The company has launched Ramelteon tablets in the strength of 8 mg after getting approval from USFDA

The network will utilise expertise, local know-how found within its membership to fullest extent

Researchers from Wellcome Sanger Institute and University of Oxford found that descendants of one multi-drug resistant malaria…

The drug will be manufactured at group's formulations manufacturing facility at SEZ, Ahmedabad

Lonza’s expansion will meet development, manufacturing needs of pharma and biotech companies developing a new generation of…

The steps tend to create awareness among parents of newborns about the importance of vaccination

This project will develop a network of people, knowledge and technology for radical, sustainable and wholesome transformation of…

For the quarter ended 30th June, 2019, GlaxoSmithKline Pharmaceuticals' Profit After Tax grew at 28 per cent